104 related articles for article (PubMed ID: 2107491)
1. Abrogation of IL-3 dependent growth requires a functional v-src gene product: evidence for an autocrine growth cycle.
Anderson SM; Carroll PM; Lee FD
Oncogene; 1990 Mar; 5(3):317-25. PubMed ID: 2107491
[TBL] [Abstract][Full Text] [Related]
2. Retroviral infection can abrogate the factor-dependency of hematopoietic cells by autocrine and non-autocrine mechanisms depending on the presence of a functional viral oncogene.
McCubrey JA; Smith SR; Algate PA; DeVente JE; White MK; Steelman LS
Oncogene; 1993 Nov; 8(11):2905-15. PubMed ID: 8414494
[TBL] [Abstract][Full Text] [Related]
3. Induction of growth factor-independence and GM-CSF secretion by the v-src oncogene in murine myeloid cells does not require membrane association of pp60v-src.
Ostermeyer AG; Anderson SM
Exp Hematol; 1996 Feb; 24(2):176-84. PubMed ID: 8641339
[TBL] [Abstract][Full Text] [Related]
4. Expression of transfected recombinant oncogenes increases radiation resistance of clonal hematopoietic and fibroblast cell lines selectively at clinical low dose rate.
FitzGerald TJ; Henault S; Sakakeeny M; Santucci MA; Pierce JH; Anklesaria P; Kase K; Das I; Greenberger JS
Radiat Res; 1990 Apr; 122(1):44-52. PubMed ID: 2320725
[TBL] [Abstract][Full Text] [Related]
5. The v-src oncogene may not be responsible for the increased radioresistance of hematopoietic progenitor cells expressing v-src.
Santucci MA; Anklesaria P; Anderson SM; Das IJ; FitzGerald TJ; Valinsky H; Kase KR; Sakakeeny MA; Greenberger JS
Radiat Res; 1992 Mar; 129(3):297-303. PubMed ID: 1311863
[TBL] [Abstract][Full Text] [Related]
6. The v-src oncogene blocks the differentiation of a murine myeloid progenitor cell line and induces a tumorigenic phenotype.
Krüger A; Anderson SM
Oncogene; 1991 Feb; 6(2):245-56. PubMed ID: 1705687
[TBL] [Abstract][Full Text] [Related]
7. Effect of infection with murine recombinant retroviruses containing the v-src oncogene on interleukin 2- and interleukin 3-dependent growth states.
Watson JD; Eszes M; Overell R; Conlon P; Widmer M; Gillis S
J Immunol; 1987 Jul; 139(1):123-9. PubMed ID: 3495596
[TBL] [Abstract][Full Text] [Related]
8. Stimulation of pp60c-src kinase activity in FDC-P1 cells by polyoma middle-T antigen and hematopoietic growth factors.
Muser J; Kaech S; Moroni C; Ballmer-Hofer K
Oncogene; 1989 Dec; 4(12):1433-9. PubMed ID: 2480561
[TBL] [Abstract][Full Text] [Related]
9. Hematopoietic stem cell- and marrow stromal cell-specific requirements for gamma irradiation leukemogenesis in vitro.
Greenberger JS; Wright E; Henault S; Anklesaria P; Leif J; Sakakeeny MA; FitzGerald TJ; Pierce JH; Kase K
Exp Hematol; 1990 Jun; 18(5):408-15. PubMed ID: 2186923
[TBL] [Abstract][Full Text] [Related]
10. Alteration of growth and differentiation factors response by Kirsten and Harvey sarcoma viruses in the IL-3-dependent murine hematopoietic cell line 32D C13(G).
Mavilio F; Kreider BL; Valtieri M; Naso G; Shirsat N; Venturelli D; Reddy EP; Rovera G
Oncogene; 1989 Mar; 4(3):301-8. PubMed ID: 2468124
[TBL] [Abstract][Full Text] [Related]
11. A murine stromal cell line promotes the proliferation of the human factor-dependent leukemic cell line UT-7.
Auffray I; Dubart A; Izac B; Vainchenker W; Coulombel L
Exp Hematol; 1994 May; 22(5):417-24. PubMed ID: 7513651
[TBL] [Abstract][Full Text] [Related]
12. An increase in the expression and total activity of endogenous p60(c-Src) in several factor-independent mutants of a human GM-CSF-dependent leukemia cell line (TF-1).
Horn S; Meyer J; Stocking C; Ostertag W; Jücker M
Oncogene; 2003 Oct; 22(46):7170-80. PubMed ID: 14562045
[TBL] [Abstract][Full Text] [Related]
13. Introduction of v-abl oncogene induces monocytic differentiation of an IL-3-dependent myeloid progenitor cell line.
Keller JR; Ruscetti SK; Ruscetti FW
Oncogene; 1990 Apr; 5(4):549-55. PubMed ID: 2158039
[TBL] [Abstract][Full Text] [Related]
14. Mechanism of induction of transforming growth factor-beta type II receptor gene expression by v-Src in murine myeloid cells.
Park SH; Birchenall-Roberts MC; Yi Y; Lee BI; Lee DK; Bertolette DC; Fu T; Ruscetti F; Kim SJ
Cell Growth Differ; 2001 Jan; 12(1):9-18. PubMed ID: 11205746
[TBL] [Abstract][Full Text] [Related]
15. Effects of colony-stimulating factors on leukemia progenitor cells and oncogene expression.
Watson JD; Barber KE; Crosier PS
Behring Inst Mitt; 1988 Aug; (83):154-64. PubMed ID: 3071333
[TBL] [Abstract][Full Text] [Related]
16. Abrogation of factor-dependence in two IL-3-dependent cell lines can occur by two distinct mechanisms.
McCubrey J; Holland G; McKearn J; Risser R
Oncogene Res; 1989; 4(2):97-109. PubMed ID: 2785667
[TBL] [Abstract][Full Text] [Related]
17. Interaction between Raf and Myc oncogenes in transformation in vivo and in vitro.
Cleveland JL; Jansen HW; Bister K; Fredrickson TN; Morse HC; Ihle JN; Rapp UR
J Cell Biochem; 1986; 30(3):195-218. PubMed ID: 3084503
[TBL] [Abstract][Full Text] [Related]
18. The induction of growth factor-independence in murine myelocytes by oncogenes results in monoclonal cell lines and is correlated with cell crisis and karyotypic instability.
Vogt M; Lesley J; Bogenberger JM; Haggblom C; Swift S; Haas M
Oncogene Res; 1987; 2(1):49-63. PubMed ID: 2851120
[TBL] [Abstract][Full Text] [Related]
19. Effect of granulocyte-macrophage colony-stimulating factor and interleukin 3 on the v-src oncogene. Inhibition of tyrosine kinase activity in the absence of changes in gene expression.
Watson JD; Jenkins DR; Eszes M; Leung E
J Immunol; 1988 Jan; 140(2):501-7. PubMed ID: 3257240
[TBL] [Abstract][Full Text] [Related]
20. The cytokine receptor repertoire specifies autocrine growth factor production in factor-dependent cells.
Rasko JE; Metcalf D; Gough NM; Begley CG
Exp Hematol; 1995 May; 23(5):453-60. PubMed ID: 7720817
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
